Page last updated: 2024-09-04

glucagon and Dyslipidemia

glucagon has been researched along with Dyslipidemia in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (10.00)29.6817
2010's7 (70.00)24.3611
2020's2 (20.00)2.80

Authors

AuthorsStudies
Andrés, A; de Solís, AJ; Fernández, A; Gallardo, N; López, V; Mazuecos, L; Pintado, C; Rodríguez, M; Rubio, B1
Baba, K; Piccione, G; Tchio, C; Tosini, G1
Aguilera-Aguilera, R; Gonzalez-Cara, C; Mendoza, FJ; Perez-Ecija, A; Toribio, RE1
Clemmensen, C; DiMarchi, RD; Finan, B; Hofmann, SM; Jall, S; Müller, TD; Neff, F; Sachs, S; Tschöp, MH1
Bahekar, R; Jain, M; Joharapurkar, A; Kshirsagar, S; Pandey, D; Patel, D; Patel, H; Patel, M; Patel, V; Sutariya, B1
Bahekar, R; Jain, M; Joharapurkar, A; Kadam, S; Kshirsagar, S; Pandey, D; Patel, D; Patel, H; Patel, M; Patel, V; Ranvir, R; Sutariya, B1
Cardoso, CG; da Costa Aguiar Alves Reis, B; de Marco Ornelas, E; Fonseca, FLA; Lima, NEA; Maifrino, LBM; Marques, MR; Veloso, AGB1
Bianchi, L; Bonaventura, A; D'Angelo, A; Derosa, G; Fogari, E; Maffioli, P; Romano, D1
Bhasin, S; Castellani, LW; Guo, W; Hamilton, JA; Herbst, KL; Hruz, PW; Hua, N; Tu, P1
Adeli, K; Baker, C; Bradshaw, CD; Brant, AF; Cramer, CT; Filippov, S; Hanselman, JC; Houghton, JL; Hurley, TR; Naples, M; Newton, RS; Pinkosky, SL; Spahr, MA; Srivastava, RA1

Trials

1 trial(s) available for glucagon and Dyslipidemia

ArticleYear
Berberis aristata/Silybum marianum fixed combination on lipid profile and insulin secretion in dyslipidemic patients.
    Expert opinion on biological therapy, 2013, Volume: 13, Issue:11

    Topics: Adult; Anthropometry; Berberis; Bicycling; Blood Glucose; Combined Modality Therapy; Diet, Reducing; Dietary Supplements; Double-Blind Method; Drug Combinations; Dyslipidemias; Exercise Therapy; Female; Glucagon; Humans; Hypolipidemic Agents; Insulin; Insulin Secretion; Lipids; Lipoproteins; Male; Middle Aged; Overweight; Phytotherapy; Plant Preparations; Silybum marianum

2013

Other Studies

9 other study(ies) available for glucagon and Dyslipidemia

ArticleYear
Effects of Moderate Chronic Food Restriction on the Development of Postprandial Dyslipidemia with Ageing.
    Nutrients, 2019, Aug-10, Volume: 11, Issue:8

    Topics: Adiposity; Aging; Animals; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Blood Glucose; Diet, Fat-Restricted; Dietary Fats; Disease Models, Animal; Dyslipidemias; Glucagon; Insulin; Lipids; Liver; Metabolic Syndrome; Postprandial Period; Rats; Rats, Wistar; Triglycerides

2019
Removal of melatonin receptor type 1 signalling induces dyslipidaemia and hormonal changes in mice subjected to environmental circadian disruption.
    Endocrinology, diabetes & metabolism, 2021, Volume: 4, Issue:1

    Topics: Animals; Chronobiology Disorders; Dyslipidemias; Female; Ghrelin; Glucagon; Insulin; Leptin; Lipid Metabolism; Male; Mice, Knockout; Receptor, Melatonin, MT1; Resistin; Signal Transduction

2021
Energy hormone response to fasting-induced dyslipidemia in obese and non-obese donkeys.
    Veterinary journal (London, England : 1997), 2021, Volume: 271

    Topics: Adiponectin; Animals; Blood Glucose; Dyslipidemias; Energy Metabolism; Equidae; Fasting; Female; Ghrelin; Glucagon; Insulin; Insulin-Like Growth Factor I; Leptin; Lipids; Obesity

2021
Monomeric GLP-1/GIP/glucagon triagonism corrects obesity, hepatosteatosis, and dyslipidemia in female mice.
    Molecular metabolism, 2017, Volume: 6, Issue:5

    Topics: Adiposity; Animals; Diet, High-Fat; Dyslipidemias; Eating; Fatty Liver; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Male; Mice; Mice, Inbred C57BL; Obesity; Sex Factors

2017
Central administration of coagonist of GLP-1 and glucagon receptors improves dyslipidemia.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 98

    Topics: Animals; Cholesterol; Dyslipidemias; Energy Metabolism; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Homeostasis; Lipid Metabolism; Liver; Male; Mesocricetus; Obesity; Receptors, Glucagon; Signal Transduction; Triglycerides

2018
Coagonist of GLP-1 and glucagon decreases liver inflammation and atherosclerosis in dyslipidemic condition.
    Chemico-biological interactions, 2018, Feb-25, Volume: 282

    Topics: Animals; Atherosclerosis; Cholesterol; Cricetinae; Dyslipidemias; Glucagon; Glucagon-Like Peptide 1; Inflammation; Lipid Metabolism; Liver; Male; Mice; Mice, Transgenic; Receptors, Glucagon

2018
Effects of moderate exercise on biochemical, morphological, and physiological parameters of the pancreas of female mice with estrogen deprivation and dyslipidemia.
    Medical molecular morphology, 2018, Volume: 51, Issue:2

    Topics: Animals; Dyslipidemias; Estrogens; Female; Glucagon; Insulin; Intra-Abdominal Fat; Menopause; Mice, Inbred C57BL; Mice, Knockout; Ovariectomy; Pancreas; Physical Conditioning, Animal; Receptors, LDL

2018
Genetic disruption of myostatin reduces the development of proatherogenic dyslipidemia and atherogenic lesions in Ldlr null mice.
    Diabetes, 2009, Volume: 58, Issue:8

    Topics: Adipose Tissue; Animals; Atherosclerosis; Blood Glucose; Body Composition; Dyslipidemias; Gene Deletion; Glucagon; Insulin; Lipids; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Skeletal; Myostatin; Receptors, LDL

2009
AMP-activated protein kinase and ATP-citrate lyase are two distinct molecular targets for ETC-1002, a novel small molecule regulator of lipid and carbohydrate metabolism.
    Journal of lipid research, 2013, Volume: 54, Issue:1

    Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Animals; ATP Citrate (pro-S)-Lyase; Biomarkers; Calcium; Carbohydrate Metabolism; Cricetinae; Dicarboxylic Acids; Diet; Dyslipidemias; Energy Metabolism; Enzyme Activation; Enzyme Inhibitors; Fatty Acids; Female; Glucagon; Glucose; Hep G2 Cells; Humans; Lipid Metabolism; Liver; Male; Mice; Molecular Targeted Therapy; Obesity; Protein Serine-Threonine Kinases; Rats; Signal Transduction; Sterols

2013